Clinical parameters and functional tests are not predictive for in-stent restenosis

References

• Laham RJ, Carroza JP, Berger C, et al. Long term (4 to 6 years) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coll Cardiol 1996; 28: 820–26.
   PubMed Web of Science ®Google Scholar
• Edelman ER, Rogers C. Hoop dreams. Stents without restenosis. Circulation 1996; 94: 1199–202.
   PubMed Web of Science ®Google Scholar
• Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997; 30: 1428–36.
   PubMed Web of Science ®Google Scholar
• Bauters C, Hubert E, Part A, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998; 31: 1291–98.
   PubMed Web of Science ®Google Scholar
• Akiyama T, Moussa I, Reimers B, et al. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol 1998; 32: 1610–18.
   PubMed Web of Science ®Google Scholar
• Kasaoka S, Tobis JM, Akiyama T, et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 1998; 32: 1630–35.
   PubMed Web of Science ®Google Scholar
• Lablanche JM, McFadden EP, Meneveau N. Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty. Transluminale: the FACT study. Fraxiparine Angioplastie Coronaire. Circulation 1997; 96: 3396–402.
   PubMed Web of Science ®Google Scholar
• Strecker EP, Gottmann D, Boos IB, Vetter S. Low-molecular- weight heparin (reviparin) reduces the incidence of femoropopliteal in-stent stenosis: preliminary results of an ongoing study. Cardiovasc Intervent Radiol 1998; 21: 375-79.
   Web of Science ®Google Scholar
• Purcell H, Fox KM. Current roles and future possibilities for low-molecular-weight heparins in unstable angina. Eur Heart J 1998; 19 (suppl K): K18-23.
   Google Scholar
• Jeremias A, Kutscher S, Haude M, et al. Nonischemic chest pain induced by coronary interventions: a prospective study comparing coronary angioplasty and stent implantation. Circulation 1998; 98: 2656–58.
   PubMed Web of Science ®Google Scholar
• Wilson RF, Lesser JR, Laxon DD, White SW. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1989; 1: 807–11.
   PubMed Web of Science ®Google Scholar
• Felled H, Lichstein E, Schachter J, Shani J. Early and late angiographic findings of the 'no-reflow' phenomenon following direct angioplasty as primary treatment of anterior myocardial infarction. Am Heart J 1992; 123: 782–85.
   PubMed Web of Science ®Google Scholar
• Plana RN, Paik GY, Moscucci M, et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994; 89: 2514–18.
   PubMed Web of Science ®Google Scholar
• Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol 1969; 217: 703–709.
   PubMed Web of Science ®Google Scholar
• Brown AM, Malliani A. Spinal sympathetic reflexes initiated by coronary receptors. J Physiol (Lond) 1971; 212: 685–705.
   Google Scholar
• Heusch G, Deussen A, Thamer V. Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feed-back aggravation of myocardial ischemia. J Auton Nerv Syst 1985; 13: 311–26.
   PubMedGoogle Scholar
• Heusch G. Adrenergic mechanisms in myocardial ischemia. Circulation 1990; 81: 1–13.
   PubMed Web of Science ®Google Scholar
• Jones CJH, DeFily DV, Patterson J, Chilian WM. Endothelium- dependent relaxation competes with r and 2- adrenergic constriction in the coronary microcirculation. Circulation 1993; 87: 1264–74.
   PubMed Web of Science ®Google Scholar
• Gregorini L, Fajadet J, Robert G, Cassagneau B, Bernis M, Marco J. Coronary vasoconstriction following percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulation 1994; 90: 985–97.
   Web of Science ®Google Scholar
• Gregorini L, Marco J, Palombo C, et al. Post-ischemic LV dysfunction is abolished by alpha-adrenergic blockers. J Am Coll Cardiol 1998; 31: 992–1001.
   PubMed Web of Science ®Google Scholar
• Kern MJ, Deligonul U, Vandormael M. Impaired coronary vasodilator reserve in the immediate post coronary angioplasty period: analysis of coronary artery flow velocity indexes and regional cardiac venous efflux. J Am Coll Cardiol 1989; 13: 860–72.
   PubMed Web of Science ®Google Scholar
• Uren NG, Crake T, Lefroy D, de Silva R, Davies GJ, Maseri A. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol 1993; 21: 612–21.
   PubMed Web of Science ®Google Scholar
• Gregorini L, Marco J, Kozakova M, et al. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999; 99: 482–90.
   PubMedGoogle Scholar
• Lorenzoni R, Rosen SD, Camici PG. Effect of j-adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans. Am J Physiol 1996; 271: H1302–H1306.
   Google Scholar
• Kern MJ, Horowitz JD, Ganz P, et al. Attenuation of coronary vascular resistance by selective alphaj-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol 1985; 5: 840–46.
   PubMed Web of Science ®Google Scholar
• Mintz GS, Hoffmann R, Mehran R, et al. In-stent restenosis: the Washington Hospital Center experience. Am J Cardiol 1998; 81(7A): 7E-13E.
   Google Scholar
• Beyar R, Frimerman A, Kornowski R, Foley DP. Multivessel stenting: staged vs non-staged approach. Int J Cardiovasc Intervent 1999; 2: 71–78.
   PubMedGoogle Scholar